Methylphenidate
Methylphenidate
Common brand names:
Daytrana, Cotempla XR-ODTMethylphenidate is a stimulant drug with actions similar to amphetamines. It is used as an adjunct to a complete program to treat children with attention deficit-hyperactivity disorder. Methylphenidate is also used to treat people with narcolepsy.
As of the last update, we have found no reported interactions between this medicine and specific foods, supplements, or other compounds. It is possible that unknown interactions exist. Taking medicines with meals, on an empty stomach, or with alcohol may influence their effects; refer to the manufacturers’ package information for details as this is not covered here. If you take medication, always discuss the potential risks and benefits of adding a new supplement with your doctor or pharmacist.
Last Review: 03-18-2015
![Aisle7 Logo](https://content.healthwise.net/resources/14.0/en-us/media/medical/camsupport/a7_a7logocpyrt105.gif)
Copyright © 2024 TraceGains, Inc. All rights reserved.
Please read the disclaimer about the limitations of the information provided here. Do NOT rely solely on the information in this article. The TraceGains knowledgebase does not contain every possible interaction.
Learn more about TraceGains, the company.
The information presented by TraceGains is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires December 2024.
This information does not replace the advice of a doctor. Healthwise, Incorporated, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content.